{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Amarin Corporation plc"},"Symbol":{"label":"Symbol","value":"AMRN"},"Address":{"label":"Address","value":"77 SIR JOHN ROGERSON'S QUAY BLOCK C, DUBLIN, D02 VK60, Ireland"},"Phone":{"label":"Phone","value":"+353 16699020"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"Europe"},"CompanyDescription":{"label":"Company Description","value":"Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular health. Its lead product includes Vascepa."},"CompanyUrl":{"label":"Company Url","value":"https://www.amarincorp.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Derek Kalinowski","title":"SVP-Manufacturing Operations"},{"name":"Karim Mikhail","title":"President, Chief Executive Officer &amp; Director"},{"name":"Steven B. Ketchum","title":"Chief Scientific Officer &amp; Executive VP"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}